# ReadCoor

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/readcoor

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.readcoor.com
- Total disclosed funding: $50M
- Latest round: Series B (Oct 3, 2019)
- Investors on record: 4

## About

Founded in 2016 and based in Massachusetts, US, ReadCoor, Inc. operates as a provider of panomic spatial sequencing platform that enables researchers to perform RNA sequencing and provides spatial image data. The company's platform operates fluorescent in situ sequencing (FISSEQ), a fundamental technology that helps clients to access clinical insight for the treatment for cancer, immuno-oncology, infectious diseases, neurological and neuromuscular diseases, brain function and cognitive disorders.

## Funding rounds

- Series B, Oct 3, 2019, $27M — Decheng Capital, Pavilion Capital
- Series A, Sep 16, 2016, $23M — Vivo Capital, Lilly Asia Ventures, Decheng Capital

## Investors

- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A
- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series A
- Decheng Capital (https://capitalatlas.ai/funds/decheng-capital) — Series A, Series B
- Pavilion Capital — Series B